monoclonal antibody Latest News

The patent cites Cleanascite™ from Biotech Support Group in a method for the selection of neutralizing antibodies to mouse IL-17F and IL-17A.

HyTest was able to maintain its high growth in 2012 despite the global economic downturn. Growth over the previous year is 25% and turnover at the end of the fiscal year ending in October was 12.7 million Euros (17 million USD).

Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

Cleanascite™ Cited In US Patent 20130011413 Titled Method and Pharmaceutical Composition for Treatment of Intestinal Disease

Cleanascite™ removes lipids for pretreatment prior to purification and preserves the protein structure and biological...

The patent cites Cleanascite™ from Biotech Support Group in a method for the selection of neutralizing antibodies to mouse IL-17F and IL-17A.

HyTest was able to maintain its high growth in 2012 despite the global economic downturn. Growth over the previous year is 25% and turnover at the end of the fiscal year ending in October was 12.7 million Euros (17 million USD).

The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies.

Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry

TRIMER Biotech, LLC is pleased to announce the successful acquisition of AME-527, an anti-TNF-α monoclonal antibody under development by Eli Lilly and Company for autoimmune disorders.

Sanomab annouces an exclusive evaluation license agreement with the National Cancer Institute (NCI) for the rights to a monoclonal antibody. Sanomab will develop the novel human therapeutic antibody for use in the treatment of pancreatic cancer.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

Vrisko limited is now providing custom antibody services produced by the hybridoma technology. Our company has reached aggreement with leader biotechnology companies to provide the best monoclonal antibody services.

ResearchInChina announces the release of a new report- China Monoclonal Antibody Industry Report, 2010-2011. For more information, please contact us at report@researchinchina.com or at 86-10-82600828.

With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.

With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.

Glenmark Pharmaceuticals announces GBR 401, an anti-CD19 monoclonal antibody. GBR 401 is developed completely in-house by Glenmark’s Biologics Research Centre located in Switzerland.

Having stepped up lifecycle management for its leading breast cancer monoclonal antibody, Herceptin, Roche hopes to encourage uptake of a more convenient formulation of the drug.

Bharatbook.com added a new report on "Monoclonal Antibody Therapeutics" this report examines the significant commercial opportunities, novel technologies and expansion into new therapeutic areas.

Monoclonal antibodies in cancer therapy – significant commercial opportunities with developing technologies and innovative products – our new report explains prospects

GenScript raises the quality standard for its antibody packages.

High quality Anti-His Monoclonal antibody developed Genscript has been widely accepted in the field.

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that an FDA advisory panel has said that Genentech/Roche's Avastin® should not receive FDA approval for breast cancer.